CIK 0001746473 · Non-accelerated filer<br>Smaller reporting company
PLIANT THERAPEUTICS, INC.
Sign in to watch- Ticker
- PLRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474272481
- Phone
- 650-481-6770
- Business address
- 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-17 | Hull Hans Chief Business Officer | Sale 10b5-1 | −9,786 | $17.23 | $169K | 185,069 |
| 2024-01-17 | Coulie Bernard President and CEO | Sale 10b5-1 | −25,721 | $17.23 | $443K | 316,382 |
| 2024-01-17 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −10,295 | $17.23 | $177K | 156,920 |
| 2024-01-17 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −5,197 | $17.23 | $90K | 55,246 |
| 2023-08-04 | Hull Hans Chief Business Officer | Option exercise 10b5-1 | +8,791 | $2.08 | $18K | 214,905 |
| 2023-08-04 | Hull Hans Chief Business Officer | Sale 10b5-1 | −20,050 | $20.01 | $401K | 194,855 |
| 2023-08-04 | Hull Hans Chief Business Officer | Option exercise · Common Stock (Right to Buy) 10b5-1 | −8,791 | 31,367 | ||
| 2023-08-03 | Hull Hans Chief Business Officer | Sale 10b5-1 | −13,069 | $20.00 | $261K | 206,114 |
| 2023-08-03 | Hull Hans Chief Business Officer | Option exercise 10b5-1 | +1,800 | $2.08 | $4K | 207,914 |
| 2023-08-03 | Hull Hans Chief Business Officer | Sale 10b5-1 | +1,800 | $20.00 | $36K | 206,114 |
| 2023-08-03 | Hull Hans Chief Business Officer | Option exercise · Common Stock (Right to Buy) 10b5-1 | −1,800 | 40,158 | ||
| 2023-07-20 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −4,755 | $17.55 | $83K | 60,443 |
| 2023-07-17 | Ouimette Mike General Counsel & Corp. Sec'y | Sale 10b5-1 | −12,778 | $18.01 | $230K | 65,198 |
| 2023-07-17 | Lefebvre Eric Chief Medical Officer | Sale 10b5-1 | −22,321 | $18.01 | $402K | 167,215 |
| 2023-07-17 | Hull Hans Chief Business Officer | Sale 10b5-1 | −17,937 | $18.01 | $323K | 219,183 |
| 2023-07-17 | Cummings Keith Lamont Chief Financial Officer | Sale 10b5-1 | −19,771 | $18.01 | $356K | 203,999 |
| 2023-07-17 | Coulie Bernard President and CEO | Sale 10b5-1 | −70,150 | $18.01 | $1.3M | 342,103 |
| 2023-07-14 | Ouimette Mike General Counsel & Corp. Sec'y | Grant or award | +27,187 | 77,976 | ||
| 2023-07-14 | Lefebvre Eric Chief Medical Officer | Grant or award | +43,750 | 189,536 | ||
| 2023-07-14 | Hull Hans Chief Business Officer | Grant or award | +35,156 | 237,120 |
Page 7 of 8 · 160 trades